Brandon Hensinger is Global Vice President at Yikon Genomics, where he has been at the forefront of many innovative breakthroughs. Most notably, he led the launch of the world’s first Non-Invasive PGT-A Technology, which is an embryo screening technology that uses non-invasive practices to help physicians choose healthy embryos for transfer, for women going through fertility treatments.
Brandon has a strong reputation as a leading sales executive, entrepreneur, and leader in the global reproductive genetics industry. He is consulted for his expertise in developing business models, strategic plans, and distribution channels for genetic laboratories, nationally and globally. He also has extensive experience in M&A due diligence operations for national and global companies.
Outside of his business life, Brandon is a competitive triathlete, rock climber, skateboarder, and musician. He is married to the love of his life and has 3 children. He loves to travel the world, enjoys exploring global cuisines, and has a love for fashion.